These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32409702)

  • 1. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC.
    Gu J; Zhang Y; Han Z; Gao L; Cui J; Sun Y; Niu Y; You B; Huang CP; Chang C; Wang X; Yeh S
    Cell Death Dis; 2020 May; 11(5):367. PubMed ID: 32409702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
    Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
    Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.
    He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S
    Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
    Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
    PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
    Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
    Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma.
    Han Z; Zhang Y; Sun Y; Chen J; Chang C; Wang X; Yeh S
    Cancer Res; 2018 May; 78(10):2550-2563. PubMed ID: 29490945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4/miR-34b-5p/c-Myc signaling.
    Wang Y; Yang Z; Gu J; Zhang Y; Wang X; Teng Z; Wang D; Gao L; Li W; Yeh S; Han Z
    FASEB J; 2022 Feb; 36(2):e22163. PubMed ID: 35061326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma.
    Tang S; Chen F; Zhang J; Chang F; Lv Z; Li K; Li S; Hu Y; Yeh S
    J Biol Chem; 2024 May; 300(5):107297. PubMed ID: 38641065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing Estrogen Receptor-β with siRNA in Cultured Cells.
    Hsu RJ; Liu JM
    Methods Mol Biol; 2016; 1366():353-358. PubMed ID: 26585149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
    Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
    Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
    Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
    EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
    Shibasaki N; Yamasaki T; Kanno T; Arakaki R; Sakamoto H; Utsunomiya N; Inoue T; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
    PLoS One; 2015; 10(6):e0130980. PubMed ID: 26114873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
    D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
    J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network.
    Ding J; Yeh CR; Sun Y; Lin C; Chou J; Ou Z; Chang C; Qi J; Yeh S
    Oncogene; 2018 Sep; 37(37):5037-5053. PubMed ID: 29789714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key sunitinib-related biomarkers for renal cell carcinoma.
    Peng Y; Dong S; Song Y; Hou D; Wang L; Li B; Wang H
    Cancer Med; 2021 Oct; 10(19):6917-6930. PubMed ID: 34402193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZDHHC2-Mediated AGK Palmitoylation Activates AKT-mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma.
    Sun Y; Zhu L; Liu P; Zhang H; Guo F; Jin X
    Cancer Res; 2023 Jun; 83(12):2034-2051. PubMed ID: 37078777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma.
    Chen SK; Wang YC; Lin TY; Wu HJ; Huang CJ; Ku WC
    Cancer Genomics Proteomics; 2021; 18(3):207-220. PubMed ID: 33893075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.